Shawn Lebsock
Optometrist · Billings, MTNPI 1124427257
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Alcon at 54.4% of the total. Reporting peaked in 2024 at $489 and has fallen 66.2% since, to $166 in 2025.
Across 28 payments — averaging $45.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$700
- Glaukos Corporation$205
- Astellas Pharma US Inc$121
- Bausch & Lomb Americas Inc.$75
- Coopervision Inc.$71
- Maculogix, Inc.$64
- plus $51 from 3 others
What the payments were for
- Food & beverage$1,26898%
- Gifts$192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 15 | $700 |
| Glaukos Corporation | 3 | $205 |
| Astellas Pharma US Inc | 1 | $121 |
| Bausch & Lomb Americas Inc. | 4 | $75 |
| Coopervision Inc. | 1 | $71 |
| Maculogix, Inc. | 1 | $64 |
| AbbVie | 1 | $30 |
| Carl Zeiss Meditec AG | 1 | $19 |
| LKC Technologies, Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ILUX$139
- Izervay$121
- DAILIES TOTAL1$113
- Precision 1$110
How this compares
$1,287 in reported general payments places this provider in the 85th percentile of 184 optometrist providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 48 | $2,565 |
| Latanoprost | 142 | $2,108 |
| Prednisolone Acetate | 58 | $1,606 |
| Timolol Maleate | 30 | $159 |
| ErythromycinErythromycin Base | 16 | $86 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Billings
- David BauerBillings$4K
- Amanda HaberBillings$2K
- Tom FelstetBillings$2K
- Blair GerrattBillings$2K
- Robyn Clausen BauerBillings$2K
- Sarah HillBillings$2K
- Brian LindeBillings$1K
- Brad KimballBillings$1K
- Jessica FerrisBillings$1K
- Joseph SteinerBillings$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.